Huile Essentielle Bio Nuit Paisible
Food supplement declared in France, declaration No 2016-7-519, decision dated 18 July 2016
Huile Essentielle Bio Nuit Paisible, from LABORATOIRES NUTRISOINS, is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Chamaemelum nobile 12.5 mg per day, Origanum majorana 12.5 mg per day, Citrus aurantium 10 mg per day, Citrus reticulata 10 mg per day, Angelica archangelica 5 mg per day. 1 rule of use applies to its ingredients (limits and warnings).
- Brand
- not provided
- Food business operator placing the product on the market
- LABORATOIRES NUTRISOINS
- Status
- Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
- Form
- Bottle
- Daily dose
- 2 gouttes
- Directions for use
- 1 goutte 2 fois par jour: le matin et soir pendant 21 jours maximum
- Not recommended (according to the manufacturer)
- Breastfeeding women, Young children (aged 1 to 3), Pregnant women, Ulcer (stomach or duodenum)
- Objectives stated by the manufacturer (these are not authorised claims)
- Sleep
Declaration 275014, procedure Article 16. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Chamaemelum nobile (L.) All. | Huile essentielle | Autre extrait fluide | 12.5 mg |
| Origanum majorana L. | Huile essentielle | Autre extrait fluide | 12.5 mg |
| Citrus aurantium L. | Huile essentielle (feuille) | Autre extrait fluide | 10 mg |
| Citrus reticulata Blanco | Huile essentielle (épicarpe) | Autre extrait fluide | 10 mg |
| Angelica archangelica L. | Huile essentielle | Autre extrait fluide | 5 mg |
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
Label warnings
Déconseillé pendant la grossesse et l’allaitement et chez l’enfant de moins de 6 ans. Ne pas utiliser en cas d’antécédents d’épilepsie, de gastrite ou d’ulcère gastrique et chez les asthmatiques. Ne pas dépasser la dose recommandée. Pas d’usage prolongé. Tenir hors de portée des enfants. Ne doit pas se substituer à un régime alimentaire varié, ni à un mode de vie sain.
Regulatory points
- Conditions légales
Citrus aurantium L.: La quantité ingérée de p-synéphrine doit être inférieure à 20 mg par dose journalière recommandée. L'étiquetage doit comporter un avertissement déconseillant l'emploi aux enfants, aux femmes enceintes ou allaitantes et en cas de traitement anti-hypertenseur. La caféine et les sources de caféine ne sont pas autorisées dans les compléments alimentaires contenant Citrus aurantium L.
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Chamaemelum nobile (L.) All.
Read the warning, when it applies and the studies cited
Roman Chamomile - Chamaemelum Nobile
Route of administration: Oral (Wichtl 2004; Bradley 1992)
Cautions and warnings
Ask a healthcare practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Known adverse reactions
Stop use if hypersensitivity/allergy occurs (Brinker 2010; Mills and Bone 2000; Blumenthal et al. 1998).
Sources cited by Health Canada (3)
- Blumenthal M, Busse WR, Goldberg A, Gruenwald J, Hall T, Riggins CW, Rister RS, editors. Herbal Medicine: Complete Commission E Monographs. Boston (MA): Integrative Medicine Communications; 1998.
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Mills S, Bone K. Principles and Practice of Phytotherapy. Toronto (ON): Churchill Livingstone; 2000.
- Angelica archangelica L.
Read the warning, when it applies and the studies cited
ANGELICA - ANGELICA ARCHANGELICA
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding (Brinker 2010; Barnes et al. 2007).
Sources cited by Health Canada (2)
- Barnes J, Anderson LA, Philipson JD. Herbal Medicines, 3rd edition. London (UK): Pharmaceutical Press; 2007.
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a peptic ulcer (Brinker 2010; Barnes et al. 2007).
Sources cited by Health Canada (2)
- Barnes J, Anderson LA, Philipson JD. Herbal Medicines, 3rd edition. London (UK): Pharmaceutical Press; 2007.
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
When using this product avoid prolonged exposure to sunlight, ultraviolet light (UV) or UV therapy (Brinker 2010; Barnes et al. 2007; Blumenthal et al. 2000).
Sources cited by Health Canada (3)
- Barnes J, Anderson LA, Philipson JD. Herbal Medicines, 3rd edition. London (UK): Pharmaceutical Press; 2007.
- Blumenthal M, Goldberg A, Brinkmann J, editors. Herbal Medicine: Expanded Commission E Monographs. Boston (MA): Integrative Medicine Communications; 2000.
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
Contraindications
Do not use if you are pregnant (Brinker 2010; Barnes et al. 2007; Blumenthal et al. 2000).
Sources cited by Health Canada (3)
- Barnes J, Anderson LA, Philipson JD. Herbal Medicines, 3rd edition. London (UK): Pharmaceutical Press; 2007.
- Blumenthal M, Goldberg A, Brinkmann J, editors. Herbal Medicine: Expanded Commission E Monographs. Boston (MA): Integrative Medicine Communications; 2000.
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Huile Essentielle Bio Nuit Paisible: composition and regulation”, https://compoatlas.com/en/supplements/products/275014-huile-essentielle-bio-nuit-paisible, updated 15 November 2026.